Volume 271, Number 50,
Issue of December 13, 1996
pp. 32002-32007
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The Q188R Mutation in Human Galactose-1-phosphate
Uridylyltransferase Acts as a Partial Dominant Negative
(Received for publication, July 11, 1996, and in revised form, September 25, 1996)
J. Patrick
Elsevier
¶
and
Judith L.
Fridovich-Keil
From the ¶ Graduate Program in Biochemistry and
Molecular Biology and the
Department of Genetics and
Molecular Medicine, Emory University, Atlanta, Georgia 30322
A longstanding goal in the fields of molecular
genetics and biochemistry has been to explain how naturally occurring
mutations associated with human metabolic disease impair activity of
the enzymes involved. This goal is particularly complex for enzymes composed of multiple subunits, because single mutations may exert both
intra- and intersubunit effects on holoenzyme structure and function.
We have previously applied a yeast coexpression system for human
galactose-1-phosphate uridylyltransferase, a dimeric enzyme associated
with galactosemia, to investigate the impact of naturally occurring
mutations on subunit association and holoenzyme function (). Here we
describe the purification and characterization of two heterodimers,
R333W/wild type (WT) and Q188R/WT, revealing that although the first
exhibits ~50% wild-type activity, the second exhibits only ~15%
wild-type activity. Neither heterodimer varied significantly from the
wild type with regard to apparent Km for either
substrate, although Q188R/WT but not R333W/WT heterodimers demonstrated
significantly increased thermal sensitivity relative to the wild-type
enzyme. These results demonstrate for the first time a partial dominant
negative effect caused by a naturally occurring mutation in human
galactose-1-phosphate uridylyltransferase.